Sydney Children's Hospital, Randwick, is an Australian children's hospital located in the eastern suburbs of Sydney, New South Wales. On 1 July 2010 it became part of the newly formed Sydney Children's Hospitals Network incorporating the Royal Alexandra Hospital for Children' and the children's hospice Bear Cottage.

There are 340 beds in Sydney Children's Hospital.

During the past decade, Sydney Children's Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 35 clinical trials were completed, i.e. on average, 54.7% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 19 clinical trials were completed. i.e. 59.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sydney Children's Hospital" #1 sponsor was "Children's Oncology Group" with 45 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Therapeutic Advances in Childhood Leukemia Consortium" with 9 trials sponsored, "Murdoch Childrens Research Institute" with 3 trials sponsored and "Nationwide Children's Hospital" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sydney Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Australian Government Department of Health and Ageing" with 3 trials as a collaborator, "Children's Hospital Colorado" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator and "Australian & New Zealand Children's Haematology/Oncology Group" with 2 trials as a collaborator. Other collaborators include 90 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "Sydney Children's Hospital" are "Sarcoma" (7 trials), "Leukemia" (6 trials), "Neuroblastoma" (6 trials), "Adult Rhabdomyosarcoma" (5 trials) and "Brain and Central Nervous System Tumors" (5 trials). Many other conditions were trialed in "Sydney Children's Hospital" in a lesser frequency.

Most popular intervention types in "Sydney Children's Hospital" are "Drug" (106 trials), "Biological" (35 trials), "Other" (33 trials), "Radiation" (25 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (20 trials), "Laboratory Biomarker Analysis" (20 trials), "Etoposide" (17 trials), "Cytarabine" (15 trials) and "cyclophosphamide" (14 trials). Other intervention names were less common.

The vast majority of trials in "Sydney Children's Hospital" are 127 trials for "All" genders.

Currently, there are NaN active trials in "Sydney Children's Hospital". undefined are not yet recruiting, 38 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Sydney Children's Hospital, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sydney Children's Hospital, 21 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".